(Q45856780)

17 December 2017

reason for preferred rank

title

Low Thymosin Alpha-1 Concentrations in Patients Chronically Infected with the Hepatitis B Virus* (English)

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

30 November 2022

Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810323

30 November 2022

1 reference

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

30 November 2022

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

30 November 2022

author name string

K. E. Sherman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810323

30 November 2022

C. C. Jones

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810323

30 November 2022

A. L. Goldstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810323

30 November 2022

P. H. Naylor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810323

30 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1810323

30 November 2022

publication date

1 January 1991

1 reference

17 December 2017

full work available at URL

https://www.liebertpub.com/doi/pdf/10.1089/vim.1991.4.195

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

30 November 2022

1 reference

17 December 2017

volume

4

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

195-199

1 reference

17 December 2017

Immunotherapy of patients with chronic virus B hepatitis. I. Maturation of human T-lymphocytes under influence of calf thymic hormone

cites work

1

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

Cellular immunity and hepatitis-associated, Australia antigen liver disease

30 November 2022

2

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

Thymosin Treatment Modulates Production of Interferon

30 November 2022

3

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

Increased thymic hormone responsive suppressor T lymphocyte function in chronic active hepatitis

30 November 2022

8

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

Thymosin in the early diagnosis and treatment of high risk homosexuals and hemophiliacs with AIDS-like immune dysfunction

30 November 2022

9

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

Approaches to the treatment of hepatitis B virus and delta-related liver disease

30 November 2022

10

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

Improved ELISA to measure thymosin alpha 1: comparison of whole and absorbed antisera

30 November 2022

11

1 reference

https://api.crossref.org/works/10.1089/VIM.1991.4.195

30 November 2022

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017